HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Non-Current Deferred Tax Liability (2014 - 2025)

HUTCHMED (China)'s (HMDCF) quarterly Non-Current Deferred Tax Liability came in at $255000.0 in Q4 2025, down 90.59% quarter-over-quarter from $2.7 million in Q4 2022.

Analysis

HUTCHMED (China) (HMDCF) Non-Current Deferred Tax Liability (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Non-Current Deferred Tax Liability for 10 consecutive years, with $255000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $255000.0 in Q4 2025; TTM through Dec 2025 was $255000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $255000.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability was $255000.0 for Q4 2025 at HUTCHMED (China), down from $2.7 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $2.8 million in Q4 2021 and troughed at $255000.0 in Q4 2025.
  • A 3-year average of $1.9 million and a median of $2.7 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability declined 22.07% in 2021 and fell 1.99% in 2022, its largest moves.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $2.8 million in 2021, then decreased by 1.99% to $2.7 million in 2022, then tumbled by 90.59% to $255000.0 in 2025.
  • The last three Non-Current Deferred Tax Liability figures came in at $255000.0 (Q4 2025), $2.7 million (Q4 2022), and $2.8 million (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.97 Bn 196.98 Bn 7.24 Bn
2 Gilead Sciences 180.98 Bn 177.80 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.09 Bn 124.24 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.57 Bn 3.93 Bn
5 Argenx Se 61.71 Bn 56.53 Bn 1.37 Bn
6 Moderna 54.60 Bn 49.46 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.02 Bn 30.71 Bn 992.69 Mn
8 Biogen 31.25 Bn 29.97 Bn 1.96 Bn
9 Roivant Sciences 29.76 Bn 29.76 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 255,000.00
Dec 31, 2022 2.71 Mn
Dec 31, 2021 2.77 Mn
Dec 31, 2020 3.55 Mn
Dec 31, 2019 2.34 Mn
Dec 31, 2018 4.26 Mn
Jun 30, 2018 5.05 Mn
Dec 31, 2017 3.82 Mn
Jun 30, 2017 4.19 Mn
Dec 31, 2016 4.99 Mn
Jun 30, 2016 2.40 Mn
Dec 31, 2015 3.47 Mn
Dec 31, 2014 2.84 Mn